NCT03177317View on ClinicalTrials.gov

Reduced Dose of Prophylactic Dexamethasone for Elderly Patients Receiving Moderate Emetogenic Chemotherapy

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

January 1, 2020

Study Completion Date

January 1, 2020

Conditions
Colonic Neoplasms
Interventions
DRUG

Dexamethasone

"Dexamethasone 8mg IV before chemotherapy on cycle 1 day 1~Once the complete response is achieved, the dose of dexamethasone will be reduced by 2 mg in the next cycle."

Trial Locations (1)

13620

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors
lead

Seoul National University Bundang Hospital

OTHER

NCT03177317 - Reduced Dose of Prophylactic Dexamethasone for Elderly Patients Receiving Moderate Emetogenic Chemotherapy | Biotech Hunter | Biotech Hunter